Only when cancer cells escape the surveillance by the immune system can a tumour grow. It is currently one challenge in cancer research to activate the body's natural defences to eliminate tumour cells. Veronika Sexl, head of the Institute of Pharmacology and Toxicology at the University of Veterinary Medicine Vienna, has now discovered with her team a surprising new function for the signalling molecule STAT1 in immune cells. This previously unknown feature could pave the way to a new therapeutic approach to immunological cancer therapy. The study results were published in the journal ‘OncoImmunology’.
The body's defences detect and eliminate not only pathogens but also tumour cells. Natural killer cells (NK-Cells) are specifically activated by chemical messengers, the Cytokines, to seek and destroy tumour cells. Veronika Sexl and her team from the Institute of Pharmacology and Toxicology at the Vetmeduni Vienna study the fundamentals of tumour surveillance by the immune system in animal models.
Cytokines trigger a signal cascade in NK cells recruiting them to tumour defence. An important player in this signalling process is the transcription factor STAT1. This molecule enters the cell nucleus to turn on genes required for the activation of NK cells. Until now it was assumed that NK cells are triggered by STAT1 mediated gene activation. However, Sexl and her team have now discovered that not gene transcription, but a previously unknown mechanism of STAT1 activates NK cells.
Genetics revealed unknown function of STAT1
The importance of the signalling molecule STAT1 for NK cells is revealed when it is absent. Without STAT1 tumour cells are inefficiently eliminated. The researchers wondered however, whether STAT1’s nuclear activity as transcriptional activator is essential for its function. "The activation of other genes is to date the only known and accepted function of STAT1. In order to show the actual role in the activation of NK cells we genetically removed this function, "said lead author Eva Putz.
To do so Sexl teamed up with researchers from the US and the University of Vienna, and generated mice with a modified STAT1. This altered STAT1 molecule is incapable of turning on genes by virtue of a single change in the protein sequence. Despite this modification, the NK cells were still surprisingly effective in eliminating tumour cells. "The activation of NK cells therefore depends on a previously unidentified STAT1 function, since the molecule without the known activity continues to function," explains Sexl.
The Immunological synapse harbours STAT1 for activation of NK cells
Using various experiments, Sexl and her co-workers could prove that STAT1 is capable of not only activating genes but also working directly with key players in the signalling process outside the nucleus. "A transcription factor performs its job in the cell nucleus, where the DNA is. But we observed STAT1 in activated NK cells not in the nucleus, but in regions close to the cell membrane, where NK cells and tumour cells meet" says Putz.
Apparently, STAT1 does not need to enter the nucleus in order to activate NK cells. Instead, STAT1 appears to be directly involved in the signalling of the NK cells, which upon activation eliminate the tumour cells. This represents a new function of STAT1, entirely independent of gene transcription.
"It will be an exciting challenge to explore this previously unknown function of STAT1 in tumour surveillance. Improving the mobilisation of NK cells in cancer patients is an intense area of research to make anti-tumour therapy more effective", concludes Sexl.
The article "Novel non-canonical role of STAT1 in natural killer cell cytotoxicity" by Eva Maria Putz, Andrea Majoros, Dagmar Gotthardt, Michaela Prchal-Murphy, Eva Maria Zebedin-Brandl, Daniela Alexandra Fux, Andreas Schlattl, Robert D. Schreiber, Sebastian Carotta, Mathias Müller, Christopher Gerner, Thomas Decker and Veronika Sexl published in the Journal OncoImmunology. doi:10.1080/2162402X.2016.1186314
About the University of Veterinary Medicine Vienna
The University of Veterinary Medicine Vienna (Vetmeduni Vienna) is one of the leading veterinary, academic and research facilities in Europe. Its main focus is on the research fields of animal health, food safety, animal husbandry and animal welfare as well as biomedical fundamentals. The Vetmeduni Vienna has 1,300 employees and is currently training 2,300 students. The campus in Floridsdorf, Vienna has five university hospitals and numerous research institutions at its disposal. Two research institutes at Wilhelminenberg, Vienna and a Teaching and Research in Lower Austria also belong to the Vetmeduni Vienna. http://www.vetmeduni.ac.at
Institute of Pharmacology and Toxikology
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-2910
Science Communication / Corporate Communications
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-1165
Mag.rer.nat Georg Mair | Veterinärmedizinische Universität Wien
Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory
Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP
Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.
Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
09.12.2016 | Life Sciences
09.12.2016 | Ecology, The Environment and Conservation
09.12.2016 | Health and Medicine